P631: A PCR-BASED ASSAY FOR IGLV3-21R110 SCREENING CONFIRMS ITS PROGNOSTIC VALUE IN AN INDEPENDENT COHORT OF 613 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000845408.45621.4a |
| _version_ | 1827336406364585984 |
|---|---|
| author | C. Syrykh N. Russiñol T. Baumann M. Kulis M. Alcoceba M. González E. Colado Á. R. Payer M. Aymerich M. J. Terol S. Ruiz-Gaspà A. López-Guillermo J. I. Martín-Subero D. Colomer J. Delgado E. Campo F. Nadeu |
| author_facet | C. Syrykh N. Russiñol T. Baumann M. Kulis M. Alcoceba M. González E. Colado Á. R. Payer M. Aymerich M. J. Terol S. Ruiz-Gaspà A. López-Guillermo J. I. Martín-Subero D. Colomer J. Delgado E. Campo F. Nadeu |
| author_sort | C. Syrykh |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:30:04Z |
| format | Article |
| id | doaj.art-83b337334f604a01bc0a3593d3a10a3d |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:30:04Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-83b337334f604a01bc0a3593d3a10a3d2024-03-02T06:40:43ZengWileyHemaSphere2572-92412022-06-01652953010.1097/01.HS9.0000845408.45621.4a202206003-00529P631: A PCR-BASED ASSAY FOR IGLV3-21R110 SCREENING CONFIRMS ITS PROGNOSTIC VALUE IN AN INDEPENDENT COHORT OF 613 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.C. Syrykh0N. Russiñol1T. Baumann2M. Kulis3M. Alcoceba4M. González5E. Colado6Á. R. Payer7M. Aymerich8M. J. Terol9S. Ruiz-Gaspà10A. López-Guillermo11J. I. Martín-Subero12D. Colomer13J. Delgado14E. Campo15F. Nadeu161 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain1 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain3 Hospital Clinic of Barcelona, Barcelona1 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain5 Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid5 Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid7 Servicio de Hematología y Hemoterapia, Hospital Universitario Central de Asturias, Oviedo7 Servicio de Hematología y Hemoterapia, Hospital Universitario Central de Asturias, Oviedo1 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain8 Servicio de Hematología, Hospital Clínico Universitario, INCLIVA, Universidad de Valencia, Valencia1 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain1 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain1 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain1 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain1 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain1 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain1 Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spainhttp://journals.lww.com/10.1097/01.HS9.0000845408.45621.4a |
| spellingShingle | C. Syrykh N. Russiñol T. Baumann M. Kulis M. Alcoceba M. González E. Colado Á. R. Payer M. Aymerich M. J. Terol S. Ruiz-Gaspà A. López-Guillermo J. I. Martín-Subero D. Colomer J. Delgado E. Campo F. Nadeu P631: A PCR-BASED ASSAY FOR IGLV3-21R110 SCREENING CONFIRMS ITS PROGNOSTIC VALUE IN AN INDEPENDENT COHORT OF 613 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. HemaSphere |
| title | P631: A PCR-BASED ASSAY FOR IGLV3-21R110 SCREENING CONFIRMS ITS PROGNOSTIC VALUE IN AN INDEPENDENT COHORT OF 613 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. |
| title_full | P631: A PCR-BASED ASSAY FOR IGLV3-21R110 SCREENING CONFIRMS ITS PROGNOSTIC VALUE IN AN INDEPENDENT COHORT OF 613 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. |
| title_fullStr | P631: A PCR-BASED ASSAY FOR IGLV3-21R110 SCREENING CONFIRMS ITS PROGNOSTIC VALUE IN AN INDEPENDENT COHORT OF 613 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. |
| title_full_unstemmed | P631: A PCR-BASED ASSAY FOR IGLV3-21R110 SCREENING CONFIRMS ITS PROGNOSTIC VALUE IN AN INDEPENDENT COHORT OF 613 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. |
| title_short | P631: A PCR-BASED ASSAY FOR IGLV3-21R110 SCREENING CONFIRMS ITS PROGNOSTIC VALUE IN AN INDEPENDENT COHORT OF 613 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. |
| title_sort | p631 a pcr based assay for iglv3 21r110 screening confirms its prognostic value in an independent cohort of 613 patients with chronic lymphocytic leukemia |
| url | http://journals.lww.com/10.1097/01.HS9.0000845408.45621.4a |
| work_keys_str_mv | AT csyrykh p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT nrussinol p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT tbaumann p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT mkulis p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT malcoceba p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT mgonzalez p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT ecolado p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT arpayer p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT maymerich p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT mjterol p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT sruizgaspa p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT alopezguillermo p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT jimartinsubero p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT dcolomer p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT jdelgado p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT ecampo p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia AT fnadeu p631apcrbasedassayforiglv321r110screeningconfirmsitsprognosticvalueinanindependentcohortof613patientswithchroniclymphocyticleukemia |